Rajiv Sood, MD
Plastic and Reconstructive Surgery · Augusta, GANPI 1235163387
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Kerecis Limited at 43.1% of the total. 2025 is the largest year on record at $159,016, 3.6 times the $43,719 reported in 2019. Among plastic and reconstructive surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $2426.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$217K
- Smith+Nephew$201K
- Avita Medical Americas, LLC$73K
- Polynovo North America LLC$4K
- Cook Biotech Incorporated$3K
- Integra Lifesciences Corporation$3K
- plus $3K from 9 others
What the payments were for
- Consulting fees$214,81443%
- Speaking & faculty fees$163,56533%
- Travel & lodging$107,94021%
- Food & beverage$12,1752%
- Education$3,7501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 60 | $216,608 |
| Smith+Nephew | 75 | $201,145 |
| Avita Medical Americas, LLC | 35 | $72,622 |
| Polynovo North America LLC | 20 | $4,220 |
| Cook Biotech Incorporated | 3 | $2,533 |
| Integra Lifesciences Corporation | 2 | $2,500 |
| Vericel Corporation | 1 | $2,200 |
| Baxter Healthcare | 3 | $160 |
| Lumenis, Inc | 1 | $94 |
| Triad Life Sciences Inc. | 1 | $40 |
| Pfizer | 2 | $34 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Sanara Medtech Inc. | 1 | $23 |
| Merck | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$449,300
- Kerecis Omega3 Marigen$259,160
- Kerecis Omega3 SurgiClose$208,508
- Kerecis GraftGuide$112,325
- ACTICOAT 4" X 4"$111,372
- Oasis$102,379
- COLLAGENASE SANTYL$98,098
- Versajet$60,075
- Kerecis Omega3 GraftGuide$52,549
- RECELL$52,291
- Biobrane$35,486
- OASIS MICRO$29,971
- Allevyn$29,628
- Santyl$18,940
- Allevyn Life$18,810
- Iodosorb$18,810
- ACTICOAT$18,790
- RENASYS TOUCH$15,871
- PICO$12,021
- ALLEVYN LIFE L 15.4X15.4 CTN10$9,063
How this compares
$502,244 in reported general payments places this provider in the 95th percentile of 83 plastic and reconstructive surgery providers in Georgia.
See all plastic and reconstructive surgery providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $3,520 |
| Amiodarone Hcl | 15 | $844 |
| Atorvastatin Calcium | 16 | $466 |
| Bumetanide | 11 | $333 |
| Pantoprazole Sodium | 18 | $310 |
| Levothyroxine Sodium | 23 | $307 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 11 | $182 |
| Oxycodone Hcl | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $34 | $3,52012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 83 plastic and reconstructive surgery providers in Georgia.
Other plastic and reconstructive surgery in Augusta
- Christopher EwartAugusta$8K
- Sma Zaheed HassanAugusta$6K
- Trevor HansenAugusta$4K
- Billy LynnAugusta$1K
- Piotr SkowronskiAugusta$1K
- George DrewAugusta$902
- Carmen KavaliAtlanta$233K
- Randal RuddermanAlpharetta$207K
- James NamnoumAtlanta$97K
- Michael MirzabeigiAtlanta$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.